PROCEPT BioRoboticsĀ® Announces First Commercial Aquablation Therapy Procedures in Japan

Go back to PROCEPT BioRoboticsĀ® Announces First Commercial Aquablation Therapy Procedures in Japan
(NASDAQ: PRCT) Delayed: 21.08 -0.57 (2.63%)
Previous Close $21.65    52 Week High
Open $21.28    52 Week Low
Day High $21.63    P/E N/A 
Day Low $20.90    EPS
Volume 166,648